INFANTILE SPASM TREATMENT MARKET ANALYSIS

Infantile Spasm Treatment Market, by Product Type (Adrenocorticotropic Hormone, Vigabatrin, and Phase III), by Route of Administration (Oral and Parenteral), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Published In : Jan 2019
Code : CMI2453
Pages :150
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Figure 1. Global Infantile Spasm Treatment Market Value (US$ Mn), by Region, 2017

Increasing adoption of infantile spasms treatment procedure in North America is expected to bolster the market growth

North America holds dominant position in the global infantile spasm treatment market, owing to high adoption of infantile spasms treatment procedures and large scale research and development activities in this region. For instance, INSYS Therapeutics developed Cannabidiol in October 2012, Oral Solution for infantile spasm, which is under phase III clinical trial. The reoccurrence of infantile spasm is a major factor that boosts the market growth.